Literature DB >> 14870766

Management of metastatic spinal cord compression.

Ernesto Maranzano1, Fabio Trippa, Luigia Chirico, Maria Luisa Basagni, Romina Rossi.   

Abstract

Metastatic spinal cord compression, diagnosed in 3-7% of cancer patients, is one of the most dreaded complications of metastatic cancer. It is an oncologic emergency, which must be diagnosed early and treated promptly to achieve the best results and avoid progressive pain, paralysis, sensory loss and sphincter incontinence. Patients who are ambulatory at the time of the diagnosis have a higher probability of obtaining good response to treatment and a longer survival. In clinical practice, back pain accompanies metastatic spinal cord compression in most cases, even in patients with no neurologic deficits. Magnetic resonance imaging is the best tool for diagnosing metastatic spinal cord compression and is able to identify spinal cord compression in 32-35% patients with back pain, bone metastases and normal neurologic examination. Moreover, magnetic resonance imaging gives the extension of the lesion, can diagnose other unsuspected clinical metastatic spinal cord compression sites, and is useful for the radiation oncologist in defining the target volume. Radiotherapy is the treatment of choice in most cases, whereas surgery is advised only in selected patients (ie, if stabilization is necessary, if radiotherapy has already been given in the same area, when vertebral body collapse causes bone impingement on the cord or nerve roots, when there are diagnostic doubts, or when computed tomography-guided percutaneous vertebral biopsy cannot be performed). Laminectomy should be abandoned in favor of more aggressive surgery (ie, posterior, anterior, and/or lateral approach, tumor mass resection, and stabilization of the spine). Generally, radiotherapy must be administered 7-10 days after surgery. The optimal radiation schedule has not been defined. However, as recently suggested by some clinical trials, even the hypofractionated radiotherapy regimens are effective and can be used without increasing radiation-induced myelopathy. Moderate doses of dexamethasone should be used in the early phases of therapy. After radiotherapy, spinal recurrence is generally found in sites different from the first compression area. A close post-treatment follow-up is suggested using clinical parameters (pain, motor and sphincter function), and magnetic resonance imaging should be performed only when a second metastatic spinal cord compression and/or myelopathy are clinically suspected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14870766     DOI: 10.1177/030089160308900502

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  9 in total

Review 1.  Management of metastatic sacral tumours.

Authors:  Nasir A Quraishi; Kyriakos E Giannoulis; Kimberley L Edwards; Bronek M Boszczyk
Journal:  Eur Spine J       Date:  2012-06-23       Impact factor: 3.134

2.  Interdisciplinary clinical evaluation of 58 patients with lumbar-vertebral metastases from cervico-uterine cancer.

Authors:  Víctor Valdespino Gómez; Juan M Salgado Cazares; Gaspar González Astudillo; Víctor E Valdespino Castillo
Journal:  Clin Transl Oncol       Date:  2005-11       Impact factor: 3.405

Review 3.  Palliative external-beam radiotherapy for bone metastases from hepatocellular carcinoma.

Authors:  Shinya Hayashi; Hidekazu Tanaka; Hiroaki Hoshi
Journal:  World J Hepatol       Date:  2014-12-27

4.  Surgical treatment of multiple spine metastases from gastrinoma.

Authors:  Kelli L Crabtree; Karen K Anderson; Neal G Haynes; Paul M Arnold
Journal:  Evid Based Spine Care J       Date:  2011-11

5.  Predictors of survival in surgically treated patients of spinal metastasis.

Authors:  Pravin Padalkar; Benjamin Tow
Journal:  Indian J Orthop       Date:  2011-07       Impact factor: 1.251

6.  What Is the Value of Surgical Intervention for Sacral Metastases?

Authors:  Zhiye Du; Wei Guo; Rongli Yang; Xiaodong Tang; Tao Ji; Dasen Li
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

Review 7.  Prevention and Treatment of Bone Metastases in Breast Cancer.

Authors:  Ripamonti Carla; Trippa Fabio; Barone Gloria; Maranzano Ernesto
Journal:  J Clin Med       Date:  2013-09-24       Impact factor: 4.241

8.  Does T1- and diffusion-weighted magnetic resonance imaging give value-added than bone scintigraphy in the follow-up of vertebral metastasis of prostate cancer?

Authors:  Dong Hoon Lee; Jong Kil Nam; Hee Suk Jung; Seong Jang Kim; Moon Kee Chung; Sung-Woo Park
Journal:  Investig Clin Urol       Date:  2017-08-03

9.  Instrumentation Failure after Partial Corpectomy with Instrumentation of a Metastatic Spine.

Authors:  Sung Bae Park; Ki Jeong Kim; Sanghyun Han; Sohee Oh; Chi Heon Kim; Chun Kee Chung
Journal:  J Korean Neurosurg Soc       Date:  2018-04-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.